Thousands of men a year with advanced prostate could avoid gruelling chemotherapy by combining radiotherapy and hormone therapy, a study reveals.Targeting the radiotherapy to the sites where the cancer has spread can delay further progression of the disease and the need for subsequent treatments, such as chemotherapy, which can have significant impact on a person's quality of life, researchers say.The trial demonstrated that the patients' cancer did not progress for an average of six months (6.4) and two fifths (40.1 per cent) of patients remained progression-free at 12 months.
Load More
Load More